Showing results (21-30 of 75) with videos related to
Sort By:
Pageof 8
Hinyokika Kiyo. Acta Urologica Japonica|August 14, 2008
[Ruptured pseudoaneurysm of the renal artery associated with segmental arterial mediolysis]Kosuke Mizutani, Mina Kikuchii, Hiroshi Kondo, et al.International Journal of Urology : Official Journal of the Japanese Urological Association|January 29, 2019
Utility of robot-assisted radical cystectomy with intracorporeal urinary diversion for muscle-invasive bladder cancerTakuya Koie, Chikara Ohyama, Kazuhide Makiyama, et al.Scientific Reports|January 28, 2022
Gene therapy of prostate cancer using liposomes containing perforin expression vector driven by the promoter of prostate-specific antigen geneKosuke Mizutani, Kyojiro Kawakami, Yasunori Fujita, et al.Hinyokika Kiyo. Acta Urologica Japonica|May 20, 2004
[Multiple metastases of the penile cancer: an experience of combination chemotherapy]Kosuke Mizutani, Kensaku Seike, Takashi Sugawara, et al.Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|October 14, 2022
Evaluation of physical and psychological status of health care workers infected with COVID-19 during a hospital outbreak in JapanKoji Kameyama, Kosuke Mizutani, Yukiko Miyake, et al.Anticancer Research|October 1, 2021
Kartogenin Inhibits Prostate Cancer Cell Growth Through Smad2 Activation and Decreases Androgen Receptor Nuclear LocalizationManabu Takai, Kyojiro Kawakami, Yasunori Fujita, et al.Medicine|March 31, 2021
Frequency of pre-treatment may not increase the immune-related adverse events of RCC patients treated with nivolumabKosuke Mizutani, Toshiki Ito, Kiyoshi Takahara, et al.Proceedings of the National Academy of Sciences of the United States of America|March 29, 2024
A sodium-dependent trehalose transporter contributes to anhydrobiosis in insect cell line, Pv11Kosuke Mizutani, Yuki Yoshida, Eita Nakanishi, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 22, 2020
Pembrolizumab Treatment and Pathologic Therapeutic Evaluation for Granulocyte Colony-stimulating Factor-producing Bladder Cancer: A Case Report and Literature ReviewYuka Muramatsu-Maekawa, Tomoki Taniguchi, Hiroki Ito, et al.International Journal of Oncology|December 3, 2016
Enzalutamide inhibits proliferation of gemcitabine-resistant bladder cancer cells with increased androgen receptor expressionKoji Kameyama, Kengo Horie, Kosuke Mizutani, et al.Pageof 8